Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients

NCT02853123 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium
DRUG: Olodaterol
DRUG: Tiotropium

Sponsor

Boehringer Ingelheim